Effects of a new soy/beta-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects. 2002

Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
Atherosclerosis and Dysmetabolic Disease Study Center G. Descovich, Clinical Medicine and Applied Biotechnologies D. Campanacci, University of Bologna, Italy. afgcicero@tiscalinet.it

Our aim was to test the hypocholesterolemic effect of a low-dose formulation of soy proteins supplemented with isolated b-sitosterol in a ratio of 4:1 in 20 moderately hypercholesterolemic subjects. The study has been divided in three different periods of forty days each: a stabilization diet period, then a treatment period during which all subjects assumed 10 g one time a day of the tested product and, finally, a wash out period. From the end of the stabilization diet period to the end of the soy protein added in b-sitosterol supplementation we observed a 0.45 +/- 0.30 mmol/L, 0.09 +/- 0.31 mmol/L and 0.17 +/- 0.22 mmol/L mean +/- SE decrease in respectively LDL-C, TG and apoB levels, associated with a 0.12 +/- 0.25 and 0.03 +/- 0.51 mg/dL mean increase respectively in HDL-C and apoA plasma concentrations. According to this recommends, low doses of soy protein added in b-sitosterol seems to be a practical and safe alternative for patients seeking modest reductions in LDL-C (< 15%).

UI MeSH Term Description Entries
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic
D001054 Apolipoproteins A Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apo-A,ApoA
D012855 Sitosterols A family of sterols commonly found in plants and plant oils. Alpha-, beta-, and gamma-isomers have been characterized.

Related Publications

Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
January 2002, The Journal of clinical endocrinology and metabolism,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
October 2004, European journal of nutrition,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
June 1988, Atherosclerosis,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
August 2005, Journal of the American College of Nutrition,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
July 2002, The American journal of clinical nutrition,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
May 2000, The American journal of clinical nutrition,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
March 2000, Arquivos brasileiros de cardiologia,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
February 2001, The American journal of clinical nutrition,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
January 1995, Atherosclerosis,
Arrigo F G Cicero, and Alessia Fiorito, and Maria Panagiota Panourgia, and Zina Sangiorgi, and Antonio Gaddi
April 1984, International journal of clinical pharmacology, therapy, and toxicology,
Copied contents to your clipboard!